Cencora (COR) Stock Insights

COR$339.09-2.16 -0.63%
Medical - DistributionLarge Cap
Compare
Market cap$64.71BEnterprise value$71.09BRevenue (TTM)$337.4BMarket positionTop 25%

Score

43
Bearish
Value
39
Quality
43
Growth
48

Insights

  • Revenue by product
  • Revenue by region
Revenue by product
PeriodValue
FY2012Intersegment Eliminations: -184482000.0, Other Segments: 1324744000.0, Pharmaceutical Distribution: 78349334000.0
FY2013Intersegment Eliminations: -192332000.0, Other Segments: 1763549000.0, Pharmaceutical Distribution: 86387950000.0
FY2014Intersegment Eliminations: -263989000.0, Other Segments: 2449149000.0, Pharmaceutical Distribution: 117383967000.0
FY2015Other Segments: 4772178000.0, Pharmaceutical Distribution: 131480550000.0
FY2016Other Segments: 6386917000.0, Pharmaceutical Distribution: 140731224000.0
FY2017Other Segments: 5747863000.0, Pharmaceutical Distribution: 147453495000.0
FY2018Other Segments: 6332730000.0, Pharmaceutical Distribution: 161699343000.0
FY2019Animal Health: 3975232000.0, International Healthcare Solutions: 2893109000.0, Other Segments: 6868341000.0, Pharmaceutical Distribution: 172813537000.0
FY2020Animal Health: 4216462000.0, International Healthcare Solutions: 3308640000.0, Other Segments: 7525102000.0, Pharmaceutical Distribution: 182467189000.0
FY2021Animal Health: 4684417000.0, International Healthcare Solutions: 11290382000.0
FY2022Animal Health: 4216462000.0, International Healthcare Solutions: 26491673000.0, Pharmaceutical Distribution: 182171487000.0
FY2023Animal Health: 5042549000.0, International Healthcare Solutions: 27418679000.0, Pharmaceutical Distribution: 229716669000.0
FY2024Animal Health: 5365518000.0, International Healthcare Solutions: 28627542000.0, Pharmaceutical Distribution: 259973909000.0
FY2025Animal Health: 5694517000.0, International Healthcare Solutions: 30366323000.0, Pharmaceutical Distribution: 285287506000.0
Revenue by region
PeriodValue
FY2012Other Segments: 1324744000.0
FY2013Other Segments: 1763549000.0
FY2014Other Segments: 2449149000.0
FY2015Other Segments: 4772178000.0
FY2017Other Segments: 5747863000.0
FY2018Other Segments: 6332730000.0
FY2019Other Segments: 6868341000.0
FY2020Other Segments: 7525102000.0
FY2021Other Segments: 15974799000.0
FY2022International Healthcare Solutions: 26491673000.0, U.S. Healthcare Solutions: 186387949000.0
FY2023International Healthcare Solutions: 27418679000.0, U.S. Healthcare Solutions: 234759218000.0
FY2024International Healthcare Solutions: 28627542000.0, U.S. Healthcare Solutions: 265339427000.0
FY2025International Healthcare Solutions: 30366323000.0, U.S. Healthcare Solutions: 290982023000.0

Cencora (COR) Stock Insights

COR price $339.09 -2.16 -0.63%

Ticker
COR
Price
$339.09
Change
-2.16 -0.63%
Market cap
$64.71B
P/E
18.69
Forward P/E
17.35
Dividend yield
0.68%
Beta
0.58
Sector
Healthcare
Industry
Medical - Distribution
Stocklytics score
43
Value
39
Quality
43
Growth
48

Stocklytics score rationale: value 39, quality 43, growth 48.

AI Score 75. Cencora, Inc. has a market cap of $67.55 billion and a price of $354, indicating a solid valuation with a price-to-earnings ratio of approximately 19.7

Insights

Revenue by product
PeriodValue
FY2012Intersegment Eliminations: -184482000.0, Other Segments: 1324744000.0, Pharmaceutical Distribution: 78349334000.0
FY2013Intersegment Eliminations: -192332000.0, Other Segments: 1763549000.0, Pharmaceutical Distribution: 86387950000.0
FY2014Intersegment Eliminations: -263989000.0, Other Segments: 2449149000.0, Pharmaceutical Distribution: 117383967000.0
FY2015Other Segments: 4772178000.0, Pharmaceutical Distribution: 131480550000.0
FY2016Other Segments: 6386917000.0, Pharmaceutical Distribution: 140731224000.0
FY2017Other Segments: 5747863000.0, Pharmaceutical Distribution: 147453495000.0
FY2018Other Segments: 6332730000.0, Pharmaceutical Distribution: 161699343000.0
FY2019Animal Health: 3975232000.0, International Healthcare Solutions: 2893109000.0, Other Segments: 6868341000.0, Pharmaceutical Distribution: 172813537000.0
FY2020Animal Health: 4216462000.0, International Healthcare Solutions: 3308640000.0, Other Segments: 7525102000.0, Pharmaceutical Distribution: 182467189000.0
FY2021Animal Health: 4684417000.0, International Healthcare Solutions: 11290382000.0
FY2022Animal Health: 4216462000.0, International Healthcare Solutions: 26491673000.0, Pharmaceutical Distribution: 182171487000.0
FY2023Animal Health: 5042549000.0, International Healthcare Solutions: 27418679000.0, Pharmaceutical Distribution: 229716669000.0
FY2024Animal Health: 5365518000.0, International Healthcare Solutions: 28627542000.0, Pharmaceutical Distribution: 259973909000.0
FY2025Animal Health: 5694517000.0, International Healthcare Solutions: 30366323000.0, Pharmaceutical Distribution: 285287506000.0
Revenue by region
PeriodValue
FY2012Other Segments: 1324744000.0
FY2013Other Segments: 1763549000.0
FY2014Other Segments: 2449149000.0
FY2015Other Segments: 4772178000.0
FY2017Other Segments: 5747863000.0
FY2018Other Segments: 6332730000.0
FY2019Other Segments: 6868341000.0
FY2020Other Segments: 7525102000.0
FY2021Other Segments: 15974799000.0
FY2022International Healthcare Solutions: 26491673000.0, U.S. Healthcare Solutions: 186387949000.0
FY2023International Healthcare Solutions: 27418679000.0, U.S. Healthcare Solutions: 234759218000.0
FY2024International Healthcare Solutions: 28627542000.0, U.S. Healthcare Solutions: 265339427000.0
FY2025International Healthcare Solutions: 30366323000.0, U.S. Healthcare Solutions: 290982023000.0

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener